IRADIMED CORPORATION (IRMD)

NASDAQ: IRMD · Real-Time Price · USD

87.46

+1.58 (1.84%)

At close: Oct 9, 2026, 4:00 PM EDT

87.45

-0.01 (-0.01%)

After-hours: Oct 9, 2026, 7:30 PM EDT

IRADIMED CORPORATION Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,118	1,238	697	598	356	570
Market Cap Growth	14.36%	77.54%	16.49%	68.32%	-37.66%	103.87%
Enterprise Value	1,059	1,181	646	554	302	514
Last Close Price	87.45	96.65	53.79	45.98	26.22	41.97

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	48.86	55.05	36.24	34.81	27.71	61.16
Forward PE	40.18	54.04	34.59	33.91	26.07	65.08
PS Ratio	12.95	14.77	9.52	9.13	6.67	13.64
PB Ratio	10.99	13.08	8.03	8.38	4.83	7.90
P/TBV Ratio	11.37	13.56	8.33	8.69	4.97	8.03
P/FCF Ratio	44.52	72.02	39.56	99.33	38.56	52.93
P/OCF Ratio	41.21	49.61	27.20	44.44	35.40	50.66
PEG Ratio	3.35	0.77	0.77	0.77	0.77	0.77

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	12.27	14.09	8.81	8.45	5.67	12.28
EV/EBITDA Ratio	36.29	43.24	28.34	26.62	18.54	45.75
EV/EBIT Ratio	38.44	45.17	29.39	27.64	19.34	52.31
EV/FCF Ratio	42.17	68.73	36.64	91.92	32.78	47.66

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-	-	0	0.03	0.03	0.03
Debt / EBITDA Ratio	-	-	0.00	0.10	0.13	0.21
Debt / FCF Ratio	-	-	0	0.34	0.24	0.23
Net Debt / Equity Ratio	-0.58	-0.54	-0.60	-0.67	-0.76	-0.83
Net Debt / EBITDA Ratio	-2.02	-1.87	-2.29	-2.29	-3.42	-5.35
Net Debt / FCF Ratio	-2.35	-2.98	-2.96	-7.92	-6.05	-5.57
Asset Turnover	0.78	0.81	0.77	0.74	0.63	0.54
Inventory Turnover	1.78	1.77	1.46	1.69	2.49	2.37
Quick Ratio	7.89	6.37	7.38	3.80	8.33	9.91
Current Ratio	9.46	7.98	8.84	4.66	9.06	11.18
Return on Equity (ROE)	23.52%	24.78%	24.31%	23.70%	17.59%	13.96%
Return on Assets (ROA)	15.56%	15.78%	14.41%	14.10%	11.60%	7.97%
Return on Invested Capital (ROIC)	50.37%	53.11%	59.72%	76.15%	82.40%	76.68%
Return on Capital Employed (ROCE)	26.00%	26.50%	24.50%	26.40%	20.30%	12.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.06%	1.82%	2.76%	2.87%	3.61%	1.64%
FCF Yield	2.25%	1.39%	2.53%	1.01%	2.59%	1.89%
Dividend Yield	0.91%	0.73%	0.87%	0.33%	-	-
Payout Ratio	43.02%	66.90%	71.11%	76.91%	97.90%	-
Buyback Yield / Dilution	-0.41%	-0.55%	-0.48%	-0.69%	-0.36%	-1.21%
Total Shareholder Return	0.51%	0.19%	0.39%	-0.36%	-0.36%	-1.21%

SEC Filings: 10-K · 10-Q